对于高级肝细胞癌的系统治疗中的协同作用策略
Yongxin Yu1,2, Yulang Jiang2,3, Yipeng Yang2,3
1People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine Fuzhou China.
Global challenges (Hoboken, NJ)
|January 9, 2026
概括
肝细胞癌 (HCC) 治疗已经通过多酶抑制剂和免疫疗法取得了进展. 然而,低于最佳的结果凸显了对于晚期肝癌更好的治疗选择,测序和组合策略的需要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,存活率较低,特别是在晚期.
- 目前的管理面临的挑战是由于晚诊断和有限的治疗选择无法切除的疾病.
研究的目的:
- 提供对先进肝细胞癌全身疗法近期进展的综合性审查.
- 评估当前和新兴HCC治疗的临床应用和挑战.
主要方法:
- 综述广泛的研究结果和临床试验数据对HCC的全身疗法.
- 对多酶抑制剂,免疫疗法和组合疗法进行批判性分析.
主要成果:
- 多酶抑制剂 (sorafenib,lenvatinib) 和免疫疗法 (nivolumab,tremelimumab) 改善了晚期HCC的治疗结果.
- 组合疗法,如阿特佐利祖马布加贝瓦齐祖马布,在总体和无进展生存时间方面表现出显著的有效性.
结论:
- 尽管取得了进展,但低于最佳的临床试验结果需要进一步研究最佳治疗选择,测序和新的组合策略.
- 开发高级HCC的降级方法对于改善患者预后至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


